Conatus Pharmaceuticals Inc. (CNAT) jumped 7.73% or 0.15 to $2.09. It is nearly 936590 shares traded, which is 175.37% compare to the average total volume 534061. The market cap of CNAT is $69.27 million. The year to date change is 14.91%. The 52 week price range is from $1.15 to $7.95. Price of CNAT have changed 3.19% during last week. It have changed 8.99% over last month, -58.99% over last 3 months, -61.20% over last 6 months and -63.53% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CNAT is 1.85. It is -11.48% below current price. The 200-day Moving Averages for CNAT is 3.82. It is 82.78% above current price. The 52-week High is 7.95. It is 280.38% from the current price. The 52-week Low is 1.15. It is -44.98% from current price.
There are some statistics of CNAT. It is has market cap $69.27 million. The share outstanding is 33.14 million. The average volume is 534061. The percent of top 15 Institution holding is 36.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CNAT is -77.08%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CNAT is -25.05%.